Tag: iShares U.S. Pharmaceuticals ETF

Eli Lilly shares slide after a bearish Wall Street analyst call — here’s our view

Hims & Hers shares surge 50% after Novo Nordisk drops patent infringement case over compounded weight loss drugs

Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.

Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly

Novartis, Genentech file suit alleging illegal importation of prescription drug

Healthy Returns: What’s next for Novo Nordisk’s next-generation obesity drug CagriSema after trial miss

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen

Novo Nordisk sinks 15% after weight loss drug fails to match Eli Lilly’s in trial